RTX Q3 Beats Operationally but Valuation Remains Stretched; WAIT Rating Maintained

What happened

RTX's Q3 results exceeded operational expectations across revenue, operating profit, and EPS, driven by robust demand in both commercial aftermarket and defense. The company reported a record $340 billion backlog, split almost evenly between commercial aviation ($176B) and defense ($164B), providing multi-year revenue visibility. However, relative valuation metrics show RTX trading at 37.9x earnings and 21.7x EV/EBITDA, which is 21–44% above peer-implied fair value depending on the metric. The core issue is not demand but conversion: supply-chain disruptions, tariff exposure, and repair-throughput bottlenecks still threaten timely cash realization from the backlog. Master report analysis supports a WAIT rating, with no margin of safety at current levels and an attractive entry only below $195.

Implication

The Q3 beat validates operational momentum but does not resolve the valuation gap; the stock likely remains rangebound unless free cash flow guidance is raised again. Short-term holders may consider trimming positions above $235, as the market appears to fully price in near-term aftermarket and defense strength. Long-term investors should focus on Pratt & Whitney repair throughput improvements and Raytheon delivery acceleration as the key catalysts needed to justify the multiple. If supply-chain or tariff pressures worsen in 4Q26 or EAC charges increase, a decline toward $190 is plausible. As such, maintaining a WAIT stance with a re-assessment in 3–6 months is prudent, and any dip to $195 or below would offer a more favorable risk-reward.

Thesis delta

The Q3 report reinforces the demand narrative but does not change the WAIT thesis. Operational outperformance and record backlog are already reflected in the share price, leaving limited upside unless conversion accelerates beyond guidance. The key shift is that the bar for future execution has risen: without confirming free cash flow at the high end of guidance and easing supply-chain friction, the stock is likely to underperform.